Analyst Ratings For Cytosorbents Corporation (NASDAQ:CTSO)
Today, Aegis reiterated its Buy rating on Cytosorbents Corporation (NASDAQ:CTSO) with a price target of $9.00.
There are 6 buy ratings on the stock.
The current consensus rating on Cytosorbents Corporation (NASDAQ:CTSO) is Buy (Score: 3.00) with a consensus target price of $12.38 per share, a potential 142.65% upside.
Some recent analyst ratings include
- 7/25/2017-Aegis Reiterated Rating of Buy.
- 6/7/2017-Cowen and Company initiated coverage with a Outperform rating.
- 5/15/2017-B. Riley Reiterated Rating of Buy.
- 10/4/2016-Brean Capital initiated coverage with a Buy rating.
- 10/29/2015-WBB Securities Upgrade from a “Speculative Buy ” rating to a ” Buy” rating.
Recent Insider Trading Activity For Cytosorbents Corporation (NASDAQ:CTSO)
Cytosorbents Corporation (NASDAQ:CTSO) has insider ownership of 5.60% and institutional ownership of 8.75%.
- On 6/9/2017 Eric R Mortensen, Insider, bought 2,500 with an average share price of $4.04 per share and the total transaction amounting to $10,100.00. View SEC Filing
- On 6/9/2017 Michael G. Bator, Director, bought 1,500 with an average share price of $4.12 per share and the total transaction amounting to $6,180.00. View SEC Filing
- On 6/8/2017 Phillip P. Chan, Insider, bought 3,700 with an average share price of $4.00 per share and the total transaction amounting to $14,800.00. View SEC Filing
- On 6/8/2017 Vincent Capponi, COO, bought 2,500 with an average share price of $4.00 per share and the total transaction amounting to $10,000.00. View SEC Filing
- On 6/5/2017 Phillip P. Chan, Insider, bought 6,300 with an average share price of $4.00 per share and the total transaction amounting to $25,200.00. View SEC Filing
- On 5/15/2017 Kathleen P. Bloch, CFO, bought 1,000 with an average share price of $4.34 per share and the total transaction amounting to $4,340.00. View SEC Filing
- On 12/9/2016 Phillip P. Chan, Insider, bought 4,600 with an average share price of $5.40 per share and the total transaction amounting to $24,840.00. View SEC Filing
Recent Trading Activity for Cytosorbents Corporation (NASDAQ:CTSO)
Shares of Cytosorbents Corporation closed the previous trading session at 5.00 down -0.10 -1.96% with 55,718 shares trading hands.